Showing results (121-130 of 344) with videos related to

Sort By:
Pageof 35
Chemical Communications (Cambridge, England)|May 17, 2017
Synthesis and activation potential of an open shell diphosphineKai Helmdach, Stephan Ludwig, Alexander Villinger, et al.
Plos One|February 8, 2014
Human metapneumovirus: insights from a ten-year molecular and epidemiological analysis in GermanyJanine Reiche, Sonja Jacobsen, Katrin Neubauer, et al.
Bioorganic & Medicinal Chemistry Letters|August 7, 2014
Inhibitory potency of flavonoid derivatives on influenza virus neuraminidaseChristin Rakers, Sverre-Morten Schwerdtfeger, Jérémie Mortier, et al.
Nature Communications|February 5, 2024
The host RNA polymerase II C-terminal domain is the anchor for replication of the influenza virus genomeTim Krischuns, Benoît Arragain, Catherine Isel, et al.
Cellular Microbiology|September 9, 2011
Phosphatidylinositol-3-kinase (PI3K) is activated by influenza virus vRNA via the pathogen pattern receptor Rig-I to promote efficient type I interferon productionEike R Hrincius, Rüdiger Dierkes, Darisuren Anhlan, et al.
Antiviral Research|July 11, 2018
The clinically approved MEK inhibitor Trametinib efficiently blocks influenza A virus propagation and cytokine expressionTobias Schräder, Sabine E Dudek, André Schreiber, et al.
Blood|January 25, 2007
Activation of MAP kinase p38 is critical for the cell-cycle-controlled suppressor function of regulatory T cellsHenric S Adler, Sebastian Kubsch, Edith Graulich, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 25, 2010
Retrospective study of neoadjuvant versus adjuvant radiochemotherapy in locally advanced noninflammatory breast cancer : survival advantage in cT2 category by neoadjuvant radiochemotherapyStephan Ludwig Roth, Werner Audretsch, Hans Bojar, et al.
Annals of the New York Academy of Sciences|March 23, 2004
Caspase inhibitors as a supplement in immune activation therapies to achieve eradication of HIV in its latent reservoirsCarsten Scheller, Sieghart Sopper, Eleni Koutsilieri, et al.
Vaccines|October 26, 2021
Shooting at a Moving Target-Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine DevelopmentFranziska Günl, Angeles Mecate-Zambrano, Selina Rehländer, et al.
Pageof 35